OCT. 8, 2020
By Daniel Uria
Oct. 8 (UPI) -- The Supreme Court on Thursday declined to lift a nationwide injunction preventing the Trump administration from regulating a pill commonly used for medication abortions.
In its first action on reproductive rights since the death of Justice Ruth Bader Ginsburg, the shorthanded court rejected the bid to remove the emergency stay against restoring regulations that require patients to see a medical provider before receiving Mifeprex.
Opinion by Rachel Rebouché
Oct. 5, 2020
A newly configured Supreme Court featuring a Justice Amy Coney Barrett need not overturn Roe v. Wade to gut abortion rights. The court stands poised to permit states and the federal government unfettered discretion to restrict abortion on the thinnest of justifications. The most immediate example is before the court now and could have repercussions for policies aimed at curbing the covid-19 pandemic.
Since approving medication abortion 20 years ago, the Food and Drug Administration has required in-person delivery of the first drug, mifepristone, that precipitates a nonsurgical abortion. In July, the federal district court in Maryland suspended the in-person requirement during the pandemic, ruling that the FDA’s restriction was unnecessary, given the safety and efficacy of medication abortion, and that it endangered patients who should otherwise minimize contact with providers.
BY KATE SMITH, CBS NEWS
OCTOBER 5, 2020
In the wake of Justice Ruth Bader Ginsburg's death, millions of Americans wondered what the future of abortion access might look like. They won't wait long to find out.
Any day now, the current eight-justice Supreme Court is expected to issue its first decision on abortion access. The case, Food and Drug Administration v. American College of Obstetricians and Gynecologists, considers abortion via pill and whether patients, in the midst of a deadly pandemic, should still be required to make an in-person trip to a doctor's office in order to receive the medication.
After 20 years in the U.S., medication abortion is finally widely accessible through telehealth. But a looming Supreme Court ruling could change all that.
BY RUTH READER
In April of this year, when some of Minnesota’s already few abortion clinics started to close because of the pandemic, a new organization popped up with a novel idea: It would bring abortion services to Minnesotans using a mobile clinic. Called Just The Pill, its goal was to connect the state’s most rural corners with medication abortion care, a two-pill regimen that can end a pregnancy.
In the past, it’s been hard for sexual health groups to get medication abortion to people in remote areas. The Food and Drug Administration restricts one of the medications, mifepristone, in several ways. Patients must take the pill at a clinic, for example. On top of that, states have their own rules that can further encumber access. However, the medical data overwhelmingly shows the abortion pill is safe, even to take at home alone. Health experts say politics—not data—are informing these rules.
The Trump administration could force abortion patients to have unnecessary surgeries.
By Ian Millhiser
Sep 9, 2020
Last June, Chief Justice John Roberts provided a brief reprieve to abortion providers — joining his liberal colleagues in striking down a Louisiana anti-abortion law. But that reprieve could be very short-lived: A case now before the justices could give them a vehicle to undercut the right to terminate a pregnancy. If the Trump administration gets its way in
Food and Drug Administration v. American College of Obstetricians and Gynecologists, the Supreme Court could force many patients seeking abortions to undergo unnecessary surgeries, despite the fact that those patients could safely terminate their pregnancy with medication — and that’s assuming that these individuals are able to find a doctor to perform the surgery in the first place.
Federal restrictions are limiting access to telemedicine abortion care. That needs to change
August 9, 2020
The ongoing pandemic has led to huge shifts in how we live and work, and health care is no exception. In the past few months, telehealth visits have surged more than 50 percent, enabling patients to access much of the health care they need without taking the added risk of leaving their homes.
But for people seeking reproductive health services, longstanding state and federal restrictions continue to needlessly limit their access to telemedicine abortion care.